scorecardresearch
Add as a preferred source on Google
Wednesday, January 28, 2026
TopicAPI

Topic: API

‘Lack of therapeutic justification’ — govt bans 14 combination drugs used to treat common ailments

These were a part of 344 fixed dose combinations prohibited for sale by Union Health Ministry in 2016 but the makers of 15 challenged the decision in Delhi High Court.

Inching towards self-reliance: India now makes 35 drug raw materials that were imported before

Chemicals and Fertilisers Minister Mansukh Mandaviya says move will help India become self-reliant in manufacturing key drugs. Most raw materials were so far imported from China.

CSIR working on making 56 bulk drugs in India as Modi govt wants to cut imports from China

China is the biggest supplier of ingredients for drug production in India. Govt has drawn up list of 56 APIs for essential drugs with plans to make them in India.

Drugmakers cry ‘monopoly’ as Modi govt picks 1 firm each to make over 20 key raw materials

PLI scheme is supposed to end India’s dependence on Chinese imports, but drug lobby says firms could end up dependent on one company for a molecule, increasing patients’ bills.

Pharma industry warns of Covid drug shortages as raw materials prices surge 200%

Pharma firms say suspension of cargo from China has resulted hoarding, driving up prices of raw materials, seek govt intervention immediately.

Biden can’t see Indo-Pacific and pandemic with two prisms. Covid is the new reality

One should not be surprised if it turns out that the White House wanted India to agree to some quid-pro-quo for API. The jury is still out on this.

On Camera

India-Pakistan ready for lehenga diplomacy. Maryam Sharif has made the first move

Sometimes, we end up embroidering the truth as we overthink and overanalyse a fastidious lady’s personal wardrobe preferences for significant occasions.

Most EU firms eye India expansion post-trade deal, 90% say profitability to go up—FEBI survey

FEBI survey reveals Europe’s big bet on manufacturing, innovation hub amid ‘mother of all trade deals’, but flags regulatory concerns.

India, EU sign security & defence pact. How it links Indian firms to ‘ReArm Europe’ network 

The agreement comes despite differences between India and the EU on issues such as Russia-Ukraine war, showcasing the intent to deepen strategic ties. 

Non-alignment is coming back in a new avatar: Trump-peedit alliance

No nation other than China can negotiate one-on-one with Trump on an equal footing. That’s why the middle powers who so far formed the core of multilateral bodies now feel orphaned.